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1. Introduction 
The current hypothesis that the glucocorticoids 
exert their specific effects on their target tissues by 
altering gene expression has received considerable 
support from demonstrations of the binding of 
cytosol receptor-glucocorticoid complexes to nuclei 
in cell-free systems [l-7] . 
The methods used in these experiments have involv- 
ed the incubation of isolated nuclei with cytosol 
containing glucocorticoid-receptor complexes that 
have been ‘activated’ either by increasing the tempera- 
ture or ionic strength of the cytosol [8]. Upon 
re-isolation of the nuclei by low speed centrifugation 
the radioactivity bound to the washed pellet is deter- 
mined and used to calculate the number of nuclear 
binding sites. 
While measuring the binding of the dexamethasone- 
receptor complex to rat liver nuclei in a cell-free 
system we have observed aggregation of cytosol 
proteins. These results show that a substantial propor- 
tion of the radioactivity associated with the ‘nuclear’ 
pellet obtained by low speed centrifugation is in 
fact bound to cytosol proteins which have aggregated 
and coprecipitated independently of the nuclei, leading 
to an over-estimation of the number of true nuclear 
acceptor sites. 
2. Materials and methods 
2.1. Reagents and buffers 
[ 1 ,2-3H]Dexamethasone (specific activity 28 Ci/ 
mmol) was obtained from The Radiochemical Centre, 
North-Holland Publishing Company - Amsterdam 
Amersham, Bucks., UK. Non-radioactive dexamethasone, 
Norit A activated charcoal, dithiothreitol, crystalline 
bovine serum albumin, calf thymus DNA and 2,5-di- 
phenyloxazole were obtained from the Sigma Chem- 
ical Co., St. Louis, MO., USA. Dextran TSOO was 
obtained from Pharmacia, Uppsala, Sweden. Buffer A 
was 50 mM Tris-HCl (pH 7.55) containing 250 mM 
sucrose, 25 mM KCl, 10 mM MgClz and 1 mM dithio- 
threitol. 
2.2. Preparation of labelled cytosol 
Adult male rats of the Wistar albino strain of fittus 
norwegicus were killed by a blow to the head followed 
by cervical dislocation and decapitation. Livers were 
quickly removed, washed with buffer A, blotted dry, 
weighed and then homogenized in 2 vol of buffer A. 
The homogenate was centrifuged at 408 000 X g 
(max.) for 16 min in a Spinco L2-65 ultracentrifuge 
(SW 56 rotor). After removing the upper lipid layer 
by suction, 4 vol of the supernatant (cytosol) were 
incubated at 0°C for 3-4 h with 1 vol of 0.2 PM 
[3H]dexamethasone in buffer A and with either 1 vol 
of ethylene glycol or 1 vol of 1 mM non-radioactive 
dexamethasone in ethylene glycol. The protein bound 
steroid was determined using the charcoal adsorption 
technique [9]. All operations were carried out at 
0-2”C, unless otherwise specified. 
2.3. Cell free nuclear binding of dexamethasone 
Nuclei were prepared by the method of Blobel and 
Potter [lo]. The nuclei were washed with a 0.05% 
(w/v) solution (final concentration) of Triton X-100 
in 50 mM Tris-HCl (pH 7.5), 25 mM KC1 and 5 mM 
MgClz. Washed nuclei were resuspended in buffer A 
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and to 0.4 ml of the suspension was added an equal 
volume of labelled cytosol which had been preincubat- 
ed with or without excess non-radioactive dexametha- 
sone, to allow measurement of low affinity and total 
binding respectively. The solutions were mixed, 
incubated at 20°C for 1 h then chilled in an ice bath 
for 10 min and centrifuged at 1500 X g for 7.5 min 
at 2°C. The pellet was washed twice with 1 ml of 
buffer A and the final pellet was resuspended in 
0.1 M NaOH. Aliquots were taken for determination 
of DNA, protein and radioactivity. 
Controls where the labelled cytosol was incubated 
with buffer A alone instead of with a suspension of 
nuclei were also included. High affinity binding was 
calculated by subtracting low affinity binding from 
total binding. 
2.4. Other assays 
DNA and protein were assayed by the method of 
Burton [1 1] and Lowry et al. [ 121 respectively. 
Radioactivity was measured in a Nuclear Chicago 
Isocap 300 liquid scintillation spectrometer, using a 
10 ml aliquot of Diotol [ 131. The channel ratio 
method was used for quench correction. All dpm 
were corrected for background radioactivity. 
3. Results and discussion 
When cytosol that has been preincubated with 
radioactive dexamethasone at 0°C is incubated for 
1 h at 20°C with buffered sucrose in the absence of 
nuclei, a pellet of protein is obtained on centrifuga- 
tion at 1500 X g for 7.5 min (table 1). This aggregated 
cytosol protein has associated with it specifically 
bound dexamethasone as determined by incubation 
of the cytosol with and without a 5000-fold excess 
of non-radioactive dexamethasone (table 2). 
The amount of aggregation was found to be 
directly related to the concentration of cytosol 
protein (fig.l), but independent of the concentration 
of dexamethasone (table 1) and of magnesium ions 
in the range O-40 mM (data not shown). Although the 
use of ethylene glycol as a solubilizing agent had 
some effect on the amount of aggregation, it had no 
significant effect on the binding of dexamethasone 
to the aggregate (table 2). 
Table 1 
Aggregation of cytosol protein and the effect of dexamethasone concentration 
Dexamethasone concentration (M) Aggregated protein (mg) 
0 0.190 f 0.005 (3) 
3.3 x lo-* 0.175 f 0.015 (10) 
1.7 x lo-’ 0.175 f 0.015 (9) 
0.4 ml of cytosol(6 mg protein), preincubated for 3-4 h at 0°C with the above 
concentrations of dexamethasone was diluted with an equal volume of buffer A, 
incubated at 20°C for 1 h, chilled at 0°C for 10 min then centrifuged at 1500 X g 
for 7.5 min. The pellet was washed twice with buffer A. Values are the mean 
f SEM (n) determinations. 
Table 2 
High affinity binding of dexamethasone to aggregated protein and the 
effect of ethylene glycol 
Ethylene glycol Aggregated protein (mg) Dexamethasone binding 
(dpm/mg protein) 
+ 0.175 + 0.015 (9) 28 950 + 3200 (9) 
_ 0.140 + 0.010 (6) 24 800 * 3150 (3) 
Cytosol was preincubated for 3-4 h at 0°C with dexamethasone, with or without 
ethylene glycol. 0.4 ml aliquots (6 mg protein) were treated as described in the 
legend to table 1. 
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Fig.1. Effect of protein concentration on aggregation. 0.4 ml 
aliquots of labelled cytosol containing the above amounts of 
cytosol protein were diluted with 0.4 ml of buffer A, incubat- 
ed at 20°C for 1 h, chilled at 0°C for 10 min then centrifuged 
at 1500 X g for 7.5 min. The pellet was washed twice and 
the amount of aggregated protein determined. Values are 
the mean * SEM of 3 determinations. 
The amount of aggregated protein obtained after 
preincubation with dexamethasone for 3 h at 0°C 
was not increased when the cytosol (after dilution 
with an equal volume of buffer A) was treated for a 
further hour at 2O’C. The increase in temperature 
did, however, result in an increased specific binding of 
the steroid to the aggregate (fig.2). After removal 
of the aggregated protein by centrifugation, incubation 
of the supernatant for another hour at either 0°C or 
20°C resulted in no further aggregation. 
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Fig.2. Effect of incubation at 20°C on aggregation and high 
affinity binding of dexamethasone. After a 3 h preincubation 
at O’C, 0.4 ml aliquots of labelled cytosol (5.4 mg protein) 
were diluted with 0.4 ml of buffer A, incubated at 20°C 
for beiween O-60 min, chilled at 0°C for 10 rnin, then 
centrifuged at 1500 X g for 7.5 min. The pellet was washed 
twice and the amount of aggregated protein (o-0) and 
high affinity binding of dexamethasone (o-o) determined. 
Values are the mean i SEM of 3 determinations. 
To correct for the effect of aggregated cytosol 
protein on nuclear binding assays, controls where 
cytosol was incubated with buffered sucrose instead 
of a suspension of nuclei were routinely included in 
all experiments. The significance of the controls is 
summarized in table 3. 
Table 3 
Significance of cytosol protein aggregation in nuclear binding experiments 
Non-radioactive 
dexamethasone 
Bound radioactivity (dpm) 
Cytosol + Nuclei Cytosol + Buffer A 
Control/Test 
- 8650 + 950 5850 + 750 0.67 r 0.04 
+ 600 f 100 400 f 100 0.71 f 0.07 
Cytosol was preincubated with 33 nM [‘HI dexamethasone for 3-4 h at O”C, 
with or without non-radioactive dexamethasone. 0.4 ml aliquots (6 mg protein) 
were then diluted with an equal volume of either a suspension of nuclei (0.27 mg, 
nuclear protein, Test) or buffer A (Control), incubated for 1 hat 2O”C, chilled at 0°C 
for 10 min then centrifuged at 1500 X g for 7.5 min. The pellets were washed twice 
with buffer A and the bound radioactivity measured. Values are the mean f SEM 
of 12 determinations. 
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It has been suggested that a property common to 
all steroid receptor proteins is their marked tendency 
to aggregate, and that receptor aggregation artifacts 
are a potential problem in any experiment that 
defines binding of receptors as co-sedimentation with 
nuclei, chromatin or DNA [ 141. 
The extent of aggregation that we have observed 
in our experiments (about 3% of the total cytosol 
protein) is too great to be attributable merely to 
steroid receptor aggregation and emphasizes the need 
for controls to correct for protein aggregation in any 
experiment investigating the association of protein 
with isolated nuclei. 
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